| Title |
Relationship between cognition and treatment adherence to disease-modifying therapy in multiple sclerosis: a prospective, cross-sectional study / |
| Authors |
Giedraitienė, Nataša ; Taluntienė, Vera ; Kaubrys, Gintaras Ferdinandas |
| DOI |
10.1038/s41598-022-16790-3 |
| Full Text |
|
| Is Part of |
Nature.. Berlin : Nature research. 2022, vol. 12, art. no. 12447, p. [1-7].. ISSN 0028-0836. eISSN 1476-4687 |
| Keywords [eng] |
multiple sclerosis ; adherence ; BICAMS ; disease modifying therapy ; cognitive impairment |
| Abstract [eng] |
Less than half of patients with chronic diseases, including multiple sclerosis (MS), adhere to their prescribed medications. Treatment selection is essential for patient adherence. The aim of this study was to explore the potential factors influencing nonadherence to disease-modifying therapies (DMTs) in MS. This prospective, cross-sectional study was performed at the Multiple Sclerosis Center between 2018 and 2021. In total, 85 patients were eligible for final analysis. Forty-one patient (48.2%) with MS were non-adherent to DMT. Male sex, oral administration of drugs, and longer treatment duration were associated with nonadherence. The mean Expanded Disability Status Scale score did not differ between the adherent and non-adherent patients (p > 0.05). Patients with a higher score on the Symbol Digit Modalities Test, who were receiving self-injection therapy, had shorter treatment duration, and higher disability, were more likely to be adherent to DMT than those without. To minimize nonadherence in patients with MS, the patient’s information processing speed should be considered before DMT initiation, and appropriate treatment options should be discussed. |
| Published |
Berlin : Nature research |
| Type |
Journal article |
| Language |
English |
| Publication date |
2022 |
| CC license |
|
